This project has results

Does Daily Self-Monitoring of Blood Sugar Levels Improve Blood Sugar Control and Quality of Life for Patients with Type 2 Diabetes Who Do Not Use Insulin? -- The Monitor Trial

Results Summary and Professional Abstract

Results Summary

Download Summary Español (pdf) Audio Recording (mp3)

What was the research about?

With type 2 diabetes, a person’s blood sugar levels become higher than normal because the body doesn’t make or use the hormone insulin correctly. Keeping blood sugar levels normal can help prevent health problems that affect the heart, brain, eyes, limbs, and kidneys. Many people with type 2 diabetes use diet, exercise, and medicine to manage their blood sugar levels. They may also prick their fingers and measure their blood sugar levels with personal monitors daily. People can then adjust their diets and exercise in response to the blood sugar levels. But checking takes time, the supplies can be costly, and the health benefits are not clear.

This study focused on people with type 2 diabetes who don’t take insulin. The study compared people who did and didn’t check their blood sugar levels daily to see which group did a better job keeping their blood sugar at good levels. The study looked at what happened if patients who checked their blood sugar levels also received text messages explaining their blood sugar levels. The study also looked at the effects of checking blood sugar levels daily on the people’s quality of life.

What were the results?

At the end of the one-year study, there were no differences, on average, in blood sugar levels and quality of life between people who checked their blood sugar daily and those who didn’t. People who tested their blood sugar levels daily had slightly lower blood sugar levels in the middle of the study than those who didn’t test. But this difference didn’t last until the end of the study. Among people who checked their blood sugar levels, there were no differences in blood sugar levels or quality of life between those who did and didn’t receive text messages.

Who was in the study?

The study included 450 people with type 2 diabetes in North Carolina. The people in the study were 31 to 92 years old. They didn’t take insulin, but most of them took other medicine, such as metformin or a sulphonylurea, to treat their diabetes.

What did the research team do?

The research team assigned people with type 2 diabetes to one of three study groups by chance. People in one group didn’t check their own blood sugar levels for a year. People in the other two groups checked their own blood sugar levels daily. People in both of these groups received their blood sugar level results right away. People in one of the blood sugar testing groups also got text messages with information about what their levels may mean.

The research team took the people’s blood at the start of the study and again a year later. They did a test to measure A1C in the blood samples. This test shows a person’s average blood sugar levels during the past three months. Doctors and patients use the A1C test to find out if people are managing their diabetes well. The research team looked at people’s health records to see their A1C levels between the beginning and the end of the study. The team also surveyed people about their quality of life at the start and the end of the study. The research team compared the results of the A1C test and the survey among the three groups.

What were the limits of the study?

The study didn’t have enough people from different races and ages to find out if blood sugar level testing may help manage blood sugar levels in specific groups of people. The study included people only from North Carolina. The results may be different for people from other places. People in the study didn’t always test their blood sugar levels exactly as instructed by the research team. Results may be different if people tested their blood sugar levels every day as instructed. Doctors didn’t always review the results of the blood sugar level tests or give advice about the results.

Future research could look at whether interaction, such as texting, between doctors and patients with type 2 diabetes about patients’ blood sugar level results improves patients’ blood sugar levels or quality of life.

How can people use the results?

People with type 2 diabetes who don’t use insulin can use these results to ask their doctors if they should check their blood sugar levels daily. Checking blood sugar levels daily didn’t help people in this study manage their blood sugar levels better than those who didn’t. But blood sugar level testing may be useful in some situations, such as before or after a change in diabetes medicine or to inform treatment decisions.

Professional Abstract

Objective

To assess the effects of three approaches for self-monitoring of blood glucose levels on glycemic control and health-related quality of life for patients with non-insulin-treated type 2 diabetes mellitus

Study Design

Design Element	Description
Design	Randomized controlled trial
Population	450 patients with non-insulin-treated type 2 diabetes
Interventions/ Comparators	Daily blood glucose self-monitoring with immediate delivery of reported glucose values and automated, tailored patient feedback Daily blood glucose self-monitoring with immediate delivery of reported glucose values No daily glucose monitoring
Outcomes	Primary: glycemic control (A1C) and health-related quality of life Secondary: patient-reported outcomes
Timeframe	1-year follow-up for primary outcomes

This randomized controlled trial examined the effects of three approaches for self-monitoring of blood glucose in patients with non-insulin-treated type 2 diabetes. The primary outcomes were glycemic control, as measured by reduction in A1C levels, and health-related quality of life, as measured by the 36-Item Short Form Survey. Secondary outcomes included patient-reported outcomes for self-care, treatment satisfaction, sense of self-efficacy, communication between patient and healthcare provider, hypoglycemia frequency, and healthcare use.

The study included 450 patients from 15 primary care clinics in North Carolina. The patients, ages 31 to 92 years, had A1C levels between 6.5% and 9.5% in the past six months.

Researchers randomized patients without blinding to one of the three treatment groups:

Daily blood glucose self-monitoring with immediate delivery of blood glucose values and automated, tailored patient feedback via text messages describing the meaning of the values
Daily blood glucose self-monitoring with immediate delivery of blood glucose values
No daily glucose monitoring

Researchers recorded patients’ medical histories, heights, weights, A1C levels, and quality of life scores at the outset of the study. All study participants received printed educational materials that described blood glucose goals and symptoms of hypoglycemia and hyperglycemia. After approximately one year, researchers obtained patient A1C levels from blood samples and again assessed health-related quality of life. Researchers obtained A1C levels from electronic medical records for the three-, six-, and nine-month time points. Researchers assessed secondary outcomes using questionnaires at enrollment and at approximately one year. Using analysis of covariance, the researchers compared changes in outcomes among the three groups from baseline through one year.

Results

The research team found no statistically significant differences after one year in glucose control (A1C levels) or health-related quality of life among the three groups.

The study revealed statistically significant improvement in A1C levels in both blood glucose self-monitoring groups at the three-, six-, and nine-month time points; however, this improvement disappeared by the end of the year, with A1C levels returning to baseline values.

The study identified no differences in the patient-reported secondary outcomes among the three groups.

Limitations

The study could not reveal whether glucose self-monitoring affects demographic subgroups of patients differently because it was not powered to detect clinically meaningful differences between subgroups. The study included only patients from North Carolina. The findings may not be generalizable to other geographic regions. Interactions between healthcare providers and patients to review glucose readings were minimal, and this lack of interaction may have affected patient outcomes. Patient compliance in the blood glucose self-monitoring groups decreased during the study, and some patients in the no-monitoring group reported some monitoring. These limitations reflect real-life situations in which patients may not measure their blood glucose levels in a manner consistent with monitoring protocols.

Conclusions and Relevance

Daily self-monitoring of blood glucose, even when combined with automated, tailored patient feedback, did not improve patient outcomes compared with no self-monitoring. Monitoring did not provide any long-term benefit to blood glucose control or health-related quality of life for patients with non-insulin-treated type 2 diabetes. Given the patient burden associated with self-monitoring, patients and healthcare providers should consider whether routine blood glucose self-monitoring is helpful for individual patients.

Future Research Needs

Future studies could examine the effects of daily blood glucose self-monitoring in different patient subgroups. Future studies could also address whether interaction that is more direct, such as two-way messaging, between healthcare providers and patients who are performing daily blood glucose monitoring is beneficial for glycemic control and patient quality of life.

Final Research Report

View this project's final research report.

Related PCORI Dissemination and Implementation Project

Rethink the Strip: De-adoption of Glucose Monitoring for Non-Insulin Treated Type 2 Diabetes in Primary Care

Journal Articles

JAMA Internal Medicine

Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial

Clinical Diabetes and Endocrinology

How is neighborhood social disorganization associated with diabetes outcomes? A multilevel investigation of glycemic control and self-reported use of acute or emergency health care services

BMC Health Services Research

Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol

More on this Project

Blogs

Monitor Trial Spotlighted in Prominent Blog
Aaron Carroll of the New York Times' "The Upshot" blog — who moderated a 2018 PCORI Annual Meeting plenary session about balancing benefits and potential harms of different treatment options — discussed this study's finding that routine glucose monitoring may be unnecessary for people with Type 2 diabetes who are not on insulin. Study Principal Investigator Katrina Donahue, MD, MPH, was a presenter/panelist in that session.

Videos

Helping Patients with Type 2 Diabetes Improve Blood Sugar Control (right)
Hear about whether daily self-monitoring of blood sugar levels improves blood sugar control and quality of life for patients with type 2 diabetes who do not use insulin.

Evidence Updates

Blood Sugar Testing to Manage Type 2 Diabetes in Patients Who Don't Need Insulin
It’s important for people with type 2 diabetes to keep their blood sugar at a healthy level. Many patients check their blood sugar at home each day. But checking your blood sugar daily may not help you to manage your type 2 diabetes. This study found that people with type 2 diabetes who don’t use insulin did not benefit from daily self-testing.

Peer-Review Summary

Peer review of PCORI-funded research helps make sure the report presents complete, balanced, and useful information about the research. It also confirms that the research has followed PCORI’s Methodology Standards. During peer review, experts who were not members of the research team read a draft report of the research. These experts may include a scientist focused on the research topic, a specialist in research methods, a patient or caregiver, and a healthcare professional. Reviewers do not have conflicts of interest with the study.

The peer reviewers point out where the draft report may need revision. For example, they may suggest ways to improve how the research team analyzed its results or reported its conclusions. Learn more about PCORI’s peer review process here.

In response to peer review, the PI made changes including

Adding more information about what the outcomes of the study were designed to measure and what difference in results between groups would be considered clinically meaningful
Expanding the text in places to demonstrate adherence to PCORI Methodology Standards
Providing examples of the tailored messages sent to patients who were being counseled about diabetes management without needing to test their blood glucose
Adding a discussion of possible reasons for the failure to sustain significant improvements in glycemic control seen in the intervention group at six months
Providing the context for their exploratory analyses of the association between hemoglobin A1c and compliance with self-monitoring of blood glucose

Study Protocol

View this project's study protocol.

Conflict of Interest Disclosures

View the COI disclosure form.

Project Details

Principal Investigator

Katrina Donahue, MD, MPH

Project Status

Completed; PCORI Public and Professional Abstracts, and Final Research Report Posted

Project Title

Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-Insulin Treated Diabetes

Board Approval Date

May 2013

Project End Date

November 2017

Organization

University of North Carolina Chapel Hill

Year Awarded

2013

State

North Carolina

Year Completed

2018

Project Type

Research Project

Health Conditions

Nutritional and Metabolic Disorders

Diabetes

Intervention Strategies

Behavioral Interventions
Shared Decision Making
Telemedicine
Other Health Services Interventions
Technology Interventions
Training and Education Interventions

Populations

Low Health Literacy/Numeracy
Low Income
Older Adults
Racial/Ethnic Minorities
Rural
Urban

Funding Announcement

Assessment of Prevention, Diagnosis, and Treatment Options

Project Budget

$2,112,206

DOI - Digital Object Identifier

10.25302/3.2018.CE.12114980

Study Registration Information

HSRP20143264

NCT02033499

Page Last Updated:

December 2, 2020